When & How to Use Medical Device Initial Importer Services
Importing medical devices into the United States is a highly regulated process. Foreign manufacturers must coordinate FDA registration, device authorization, import entry information, complaints, adverse-event reporting, and postmarket communications. A qualified U.S. Initial Importer service can provide the domestic regulatory structure needed to support compliant and uninterrupted market access.
Introduction
Medical devices imported into the United States must satisfy the same core FDA requirements that apply to domestically marketed devices. The foreign manufacturer must be properly registered, identify its U.S. Agent, list applicable devices, and obtain any required marketing authorization. At the border, shipment data must also be consistent with FDA and U.S. Customs and Border Protection records.
For many foreign manufacturers and distributors, these requirements can be difficult to manage from another country. Time-zone differences, unfamiliar FDA terminology, changing entry data, complaint obligations, and inspection readiness may interfere with routine commercial operations. Specialized Initial Importer services provide a U.S.-based regulatory contact capable of managing importer responsibilities while the manufacturer remains focused on design, production, quality systems, and international sales.
However, appointing an Initial Importer does not automatically transfer product ownership, manufacturer liability, Quality Management System responsibility, customs duties, or commercial distribution control. A professional relationship should clearly separate FDA Initial Importer responsibilities from the roles of manufacturer, U.S. Agent, customs broker, consignee, distributor, and Importer of Record.
Chapter 1: When and How to Use an Initial Importer Service
A foreign medical device manufacturer should establish its Initial Importer arrangement before the first commercial shipment enters the United States. Waiting until a shipment is already detained can result in storage charges, delayed deliveries, lost marketplace appointments, customer dissatisfaction, and possible refusal of admission.
An Initial Importer service is especially useful when the foreign manufacturer does not have a U.S. subsidiary, when a commercial customer refuses to accept FDA importer responsibilities, when an Amazon or third-party logistics warehouse is only receiving inventory, or when the Importer of Record is not equipped to maintain FDA complaint and MDR procedures.
Before the First Shipment
Appoint the Initial Importer, align FDA registration relationships, identify the devices and manufacturers involved, and provide accurate entry information to the customs broker.
When U.S. Customers Decline
Many distributors, warehouses, and fulfillment centers accept products physically but do not accept FDA Initial Importer duties. A separate regulatory service may therefore be required.
When Postmarket Support Is Needed
A specialized provider can establish a domestic channel for complaints, adverse events, inspection communications, and manufacturer escalation.
The process normally begins with a regulatory assessment. The Initial Importer reviews the foreign establishment’s registration, device listing relationship, product code, marketing authorization or exemption, labeling information, UDI status, shipping arrangement, broker contacts, and postmarket procedures. The parties then execute a written agreement describing responsibilities, response times, records, fees, indemnification, document access, and termination requirements.
Outsourcing the Initial Importer function does not mean outsourcing the manufacturer’s quality system. The manufacturer must continue to control design, manufacturing, labeling, complaint investigation, corrective action, supplier controls, and regulatory reporting obligations that apply directly to it.
Chapter 2: FDA Definition of an Initial Importer
“Initial importer means any importer who furthers the marketing of a device from a foreign manufacturer to the person who makes the final delivery or sale of the device to the ultimate consumer or user, but does not repackage, or otherwise change the container, wrapper, or labeling of the device or device package.”
The definition focuses on a U.S. party that receives a foreign manufacturer’s device and furthers its marketing toward the ultimate consumer or user without repackaging or relabeling it. A company that repackages or relabels the device may have additional establishment-registration and device-listing responsibilities beyond those of an Initial Importer.
For purposes of Part 807, an importer is a company or individual in the United States that is an owner, consignee, or recipient of a foreign establishment’s imported device. The definition generally excludes the ultimate consumer or patient, except where the foreign establishment ships directly to that consumer or patient.
This definition is broader than the term “Initial Importer.” Depending on the transaction, an owner, consignee, recipient, or direct-to-consumer arrangement may need careful analysis to determine which U.S. party performs the Initial Importer function.
For purposes of Part 807, this means an agent, broker, or other entity, other than a carrier, that the foreign establishment uses to facilitate importation of its device into the United States.
A customs broker, agent, or other facilitator may be identified in FDA registration information, but it is not automatically the Initial Importer. The actual activities, agreements, ownership, consignee relationships, and movement of the device must be reviewed. A carrier that merely transports goods is specifically distinguished from a party that facilitates importation.
Chapter 3: Initial Importer vs. Importer of Record
Foreign manufacturers frequently confuse the FDA Initial Importer with the CBP Importer of Record. These are separate regulatory and commercial roles. One company may perform both functions, but there is no general requirement that the same entity do so.
Initial Importer
FDA-regulated medical device role.
Registers as a medical device establishment.
Identifies foreign manufacturers whose devices it imports.
Maintains applicable complaint and MDR procedures and records.
Interfaces with FDA regarding importer compliance and inspections.
Does not automatically own the products.
Importer of Record
CBP customs-entry role.
Is responsible for customs entry accuracy and reasonable care.
Provides customs classification, value, origin, and entry information.
Arranges customs bonds and pays or secures duties, taxes, and fees.
Interfaces with CBP and normally works through a licensed customs broker.
May be the owner, purchaser, consignee, or another qualified party under customs rules.
Chapter 4: FDA Regulatory Responsibilities
Establishment Registration
An Initial Importer must register its U.S. establishment before beginning the regulated importing activity. The establishment must have a physical U.S. address staffed by individuals responsible for ensuring compliance of imported devices with applicable FDA requirements. Registration information must be reviewed and renewed during FDA’s annual registration period.
The Initial Importer must identify the foreign manufacturers whose devices it imports. The foreign manufacturer, in turn, identifies its known U.S. importers during registration. The relationship should be accurate in FDA’s registration system and consistent with the actual commercial arrangement.
Device Listing Coordination
Initial Importers generally register and identify their foreign manufacturers but do not independently list every imported device solely because they act as Initial Importer. Device listing is normally maintained by the manufacturer, specification developer, repackager, relabeler, or other establishment required to list under FDA regulations.
The Initial Importer should nevertheless confirm that the manufacturer’s registration and device listing information are active and consistent with the products offered for import. Device names, proprietary names, product codes, and premarket submission numbers should match entry documents.
Marketing Authorization
Before shipment, the parties should confirm whether the device is exempt from premarket notification or is covered by an appropriate marketing authorization, such as a 510(k) clearance, De Novo classification, Premarket Approval application, Humanitarian Device Exemption, or other applicable authorization. The Initial Importer does not issue or guarantee FDA authorization, but it should coordinate records showing the regulatory basis for lawful U.S. marketing.
Medical Device Reporting
Importers have specific obligations under the Medical Device Reporting regulation. When an importer becomes aware of information that reasonably suggests an imported device may have caused or contributed to a death or serious injury, the importer generally reports the event to FDA and the manufacturer within the applicable regulatory timeframe.
When an importer becomes aware of certain malfunctions that would be likely to cause or contribute to a death or serious injury if they were to recur, the importer generally reports the malfunction to the manufacturer. The importer must maintain MDR event files and written procedures for identifying, evaluating, and processing reportable events.
All product complaints, including events that are not ultimately reportable as MDRs, should be forwarded to the manufacturer. The manufacturer must conduct its own investigation and determine its separate reporting obligations.
Reports of Corrections and Removals
Corrections and removals may require reporting when undertaken to reduce a risk to health or remedy a violation that may present a risk to health. The Initial Importer should promptly communicate field actions, customer notices, product retrievals, software corrections, labeling corrections, and other relevant actions to the manufacturer and determine whether importer-side records or reports are required.
Medical Device Tracking
Tracking obligations apply only to devices subject to FDA tracking requirements. When applicable, records must permit the device to be tracked through the distribution chain. The manufacturer, importer, distributor, and other parties should define who maintains which data and how records will be made available during a recall or regulatory inquiry.
Complaint Handling
The Initial Importer should maintain procedures for receiving, documenting, reviewing, escalating, and forwarding complaints. Records should identify the device, model, lot or serial number when available, reporter, event date, patient outcome, alleged malfunction, and date the manufacturer was notified.
Complaint forwarding does not transfer the manufacturer’s investigation responsibilities. The foreign manufacturer remains responsible for technical evaluation, root-cause analysis, production record review, risk assessment, corrective action, and manufacturer MDR determinations.
FDA Inspection Interface
Initial Importers are subject to FDA inspection. The importer must be able to produce its registration information, identified manufacturer relationships, complaint records, MDR procedures, MDR event files, distribution information, and other records applicable to its activities.
A professional service can provide a consistent U.S. point of contact, coordinate inspection scheduling, locate importer-side records, communicate with the foreign manufacturer, and organize written responses. The service does not replace the manufacturer during an inspection of manufacturing, design, quality, or production controls.
Import Data Coordination
Import entries may include the manufacturer, consignee, Initial Importer, product code, device listing information, registration information, premarket submission number, affirmation-of-compliance codes, model, intended use, and other shipment data. Inaccurate or inconsistent information can trigger manual review, document requests, detention, examination, or refusal.
The Initial Importer should coordinate with the foreign manufacturer, Importer of Record, customs broker, freight forwarder, and consignee so that each party uses consistent regulatory information.
Chapter 5: Services Provided
Importer Registration Maintenance
Initial Importer establishment registration, annual verification, company information, and identification of relevant foreign manufacturers.
Review changes in legal name, physical address, ownership, manufacturer relationships, or service scope that may require an FDA registration update.
MDR Intake Coordination
We provide a U.S. intake channel for information involving deaths, serious injuries, and potential reportable malfunctions.
Information is documented, escalated, and coordinated with the manufacturer’s regulatory and quality contacts. Final obligations are evaluated according to the applicable importer and manufacturer procedures.
Complaint Forwarding
Complaints received by the Initial Importer are recorded and forwarded to the designated manufacturer contact within the agreed timeframe.
The manufacturer remains responsible for technical investigation, root-cause determination, CAPA (Corrective and Preventive Action), and product-quality decisions.
FDA Inspection Interface
Inspection communications, document access, scheduling, importer-side records, and responses within the scope of the Initial Importer’s activities.
Manufacturer records requested by FDA must be supplied promptly by the foreign manufacturer under the cooperation provisions of the service agreement.
Import Data Coordination
Help align manufacturer details, product codes, listing references, marketing authorization data, consignee information, and other FDA entry information.
Coordination is performed with the customs broker and Importer of Record; we do not replace the customs broker or make customs declarations unless separately authorized and legally permitted.
Regulatory Communications
Provide a structured U.S. contact for importer-related FDA communications, document requests, regulatory questions, and postmarket coordination.
When separately appointed, ITB HOLDINGS LLC may also provide U.S. Agent services. The U.S. Agent and Initial Importer roles remain distinct.
Importer-Side Record Maintenance
We organize records applicable to the Initial Importer’s activities, including complaint intake, MDR evaluations, manufacturer notifications, regulatory correspondence, and relevant distribution information.
Records belonging to the manufacturer’s quality system remain under the manufacturer’s control.
Regulatory Documentation Coordination
We coordinate access to registration, listing, labeling, authorization, UDI, shipping, and entry information needed for importer compliance and import review.
This service depends on complete and accurate information supplied by the manufacturer, seller, Importer of Record, and customs broker.
Chapter 6: What Is Not Assumed
Regulatory Service Scope
- Initial Importer registration maintenance
- Complaint receipt and forwarding
- MDR intake and importer-side coordination
- Importer record maintenance
- Import data coordination
- FDA importer inspection interface
- Regulatory communication support
Responsibilities Not Automatically Assumed
- Product ownership
- Manufacturer product-liability exposure
- Design controls and design validation
- Purchasing and supplier controls
- Production and process controls
- CAPA ownership
- Manufacturer complaint investigation
- Supplier qualification
- Distribution-chain ownership or control
- Customs brokerage
- Importer of Record responsibilities
- Customs bonds, duties, taxes, or fees
- Commercial warranties or customer refunds
- Recall funding or inventory ownership
The foreign manufacturer remains responsible for the safety, effectiveness, design, manufacture, labeling, release, and ongoing quality of its devices. The Importer of Record remains responsible for customs entry and CBP obligations. Commercial sellers and distributors remain responsible for their own warranties, customer relationships, inventory, and distribution activities.
Any additional service must be expressly described in writing. The agreement should include cooperation duties, insurance expectations, indemnification, document-access requirements, complaint-notification timelines, recall support, regulatory response procedures, fees, and termination provisions.
Chapter 7: Import Documentation
Accurate documentation is essential because FDA and CBP evaluate different but overlapping information. The foreign manufacturer, seller, Importer of Record, customs broker, Initial Importer, and consignee should use consistent names, addresses, identifiers, product descriptions, quantities, and regulatory references.
The Initial Importer may coordinate FDA regulatory information, while the customs broker transmits the entry and the Importer of Record remains responsible for customs declarations. HTS classification, valuation, duty calculations, and customs bonds should be handled by qualified customs professionals.
For medical devices, the invoice description should be specific enough to identify the device and its intended use. Generic descriptions such as “medical supplies,” “equipment,” or “samples” can delay review. The product code, manufacturer name, facility address, model, and marketing authorization data should be checked before shipment.
Chapter 8: FDA Inspections of Initial Importers
FDA may inspect an Initial Importer to evaluate compliance with registration, complaint, Medical Device Reporting, corrections and removals, tracking, and other applicable requirements. The inspection may begin with a request to confirm company identity, physical address, responsible personnel, imported manufacturers, and the categories of devices handled.
Investigators may review written MDR procedures, adverse-event files, complaint logs, manufacturer notifications, reporting decisions, distribution records, corrections and removals, and communications related to imported devices. They may also compare the devices actually imported with the manufacturers identified in FDA registration records.
Importer records should demonstrate that complaints are received, evaluated, documented, and forwarded promptly. MDR files should show how the importer determined whether an event involved a death, serious injury, or reportable malfunction. Where an importer relies on information or investigation from the foreign manufacturer, the communication trail should be preserved.
Inspection readiness requires more than storing documents. Personnel must know where records are located, how to retrieve them, who is authorized to communicate with FDA, and how urgent manufacturer assistance will be obtained. The foreign manufacturer should designate regulatory and quality contacts who can respond during U.S. business hours when necessary.
ITB HOLDINGS LLC can coordinate the Initial Importer inspection interface, including scheduling, importer-side document preparation, communication with investigators, and manufacturer escalation. However, the manufacturer must provide requested design, production, investigation, CAPA (Corrective and Preventive Action), labeling, or quality records that remain within the manufacturer’s control. Prompt cooperation is critical because incomplete or delayed responses may increase regulatory concern.
Chapter 9: Choosing an Initial Importer
Medical Device Experience
The provider should understand FDA registration, listing relationships, product codes, premarket pathways, import entries, MDR, complaints, and inspections.
Written Procedures
Look for documented complaint, MDR, escalation, record-retention, inspection, and manufacturer-notification processes.
Engagement
Adverse events and import questions are time sensitive. The provider should maintain reliable contact methods and clear escalation channels.
Bilingual Skills
Foreign manufacturers benefit from a provider that can explain U.S. requirements clearly and reduce misunderstandings across languages and time zones.
Inspection Experience
The provider should be able to organize records, coordinate with investigators, and distinguish importer records from manufacturer quality records.
Clear Contract Terms
The agreement should define scope, exclusions, fees, liability, insurance, cooperation, records, termination, and transition responsibilities.
Chapter 10: Why Foreign Manufacturers Choose ITB HOLDINGS LLC
ITB HOLDINGS LLC provides regulatory support for foreign medical device manufacturers, exporters, brand owners, and distributors seeking access to the American market. Our services are designed to create a dependable U.S. compliance interface without requiring the service provider to purchase the products or assume the manufacturer’s entire business operation.
Initial Importer and U.S. Agent Support
We can provide Initial Importer representation and, under a separate appointment, U.S. Agent services. This allows foreign manufacturers to coordinate two important U.S. regulatory functions through an experienced provider while keeping each role legally distinct.
Bilingual Regulatory Communication
Clear communication helps foreign teams understand FDA terminology, document requests, complaint escalation, shipment data, and inspection responsibilities. We work to reduce delays caused by language and time-zone differences.
Support for Different Business Sizes
Our services can support startups preparing their first shipment, established exporters entering new sales channels, and multinational manufacturers seeking a defined importer structure.
Broker and Distribution Coordination
We coordinate FDA information with customs brokers, Importers of Record, distributors, commercial customers, warehouses, Amazon-related supply chains, and other logistics providers.
Postmarket and Inspection Support
Our service includes complaint intake coordination, MDR communication, importer-side records, and FDA inspection interface support within the agreed scope.
Long-Term Regulatory Partnership
Registration, importing, complaints, and regulatory communications continue after the first shipment. We support ongoing compliance rather than treating market entry as a one-time transaction.
Frequently Asked Questions
1. Do all foreign medical device manufacturers need an Initial Importer?
A foreign manufacturer exporting devices for U.S. commercial distribution generally needs a compliant U.S. importing structure. The actual Initial Importer depends on who receives the devices and furthers their marketing. Direct-to-consumer arrangements require separate analysis.
2. Is the Initial Importer the same as the Importer of Record?
No. The Initial Importer is an FDA medical device role. The Importer of Record is responsible for customs entry and CBP compliance. One entity may perform both roles, but they can be separate.
3. Can Amazon be the Initial Importer?
An Amazon fulfillment center should not be assumed to accept Initial Importer responsibilities merely because it receives inventory. The seller should establish a qualified Initial Importer before shipping and confirm the arrangement in writing.
4. Can my customs broker be the Initial Importer?
A customs broker facilitates entry filing but does not automatically become the Initial Importer. A broker would need to independently meet the definition, accept the responsibilities, and register where required.
5. Can ITB HOLDINGS LLC serve as both U.S. Agent and Initial Importer?
Yes, when separately appointed for each role. The U.S. Agent communicates with FDA for the foreign establishment, while the Initial Importer performs importer-specific registration, complaint, MDR, and inspection functions.
6. Does the Initial Importer own my products?
Not necessarily. Initial Importer status does not automatically require the provider to purchase, own, resell, or take title to the devices.
7. Who pays customs duties and taxes?
The Importer of Record is responsible for customs entry obligations, including duties, taxes, fees, classification, valuation, and customs bonds. These are not automatically assumed by the FDA Initial Importer.
8. Who files Medical Device Reports?
Importers and manufacturers have separate MDR obligations. Importers generally report deaths and serious injuries to FDA and the manufacturer and report certain malfunctions to the manufacturer. Manufacturers evaluate and submit reports required of manufacturers.
9. Who maintains complaint records?
The Initial Importer maintains records applicable to complaints it receives and forwards complaints to the manufacturer. The manufacturer maintains its own complaint files, investigations, risk evaluations, and CAPA records.
10. Can a company change its Initial Importer?
Yes. The manufacturer should plan the transition, update registration relationships where applicable, preserve complaint and MDR records, notify brokers and customers, and prevent gaps in importer coverage.
11. What happens if FDA inspects the Initial Importer?
The Initial Importer must cooperate and provide applicable records. ITB HOLDINGS LLC can coordinate the importer interface, while the foreign manufacturer must supply manufacturer-controlled records requested by FDA.
12. Does the Initial Importer maintain device listings?
Initial Importers generally register and identify imported manufacturers. Device listings are normally maintained by establishments required to list, such as manufacturers or specification developers. The Initial Importer may coordinate and verify listing information.
13. Does FDA approve Initial Importers?
FDA registration is not an approval, certification, endorsement, or guarantee of compliance. An Initial Importer must register and continuously meet applicable regulatory responsibilities.
14. Does the Initial Importer need insurance?
Insurance expectations depend on the contractual arrangement, devices, risk profile, and business activities. The parties should discuss appropriate coverage with qualified insurance and legal professionals.
15. Can a foreign company register without an Initial Importer?
A foreign manufacturer can register its foreign establishment and designate a U.S. Agent, but it must identify known U.S. importers for devices exported to the United States. The actual commercial import arrangement must comply before importing begins.
Conclusion
The U.S. Initial Importer is a critical regulatory participant in the medical device supply chain. The role connects foreign manufacturers with FDA registration, import screening, complaint processing, Medical Device Reporting, corrections and removals, tracking where applicable, and importer inspections.
Foreign manufacturers should not assume that a warehouse, fulfillment center, customs broker, consignee, or commercial customer automatically accepts this responsibility. The role should be assigned before shipment through a clear written agreement supported by accurate FDA registration relationships, complete device information, reliable communication procedures, and defined postmarket responsibilities.
A professional Initial Importer service allows the foreign manufacturer to maintain control over design, manufacturing, quality systems, and commercial decisions while using a qualified U.S. entity for importer-specific regulatory functions. The Importer of Record can remain separately responsible for customs entry, duties, taxes, customs bonds, and other CBP requirements.
Need a Professional U.S. Initial Importer?
ITB HOLDINGS LLC provides professional FDA Initial Importer representation for foreign medical device manufacturers exporting products to the United States. Our services include Initial Importer registration maintenance, FDA regulatory communications, complaint intake coordination, MDR support, import data coordination, importer-side records, and FDA inspection interface services.
Your company remains the manufacturer and, when applicable, the Importer of Record, while we help maintain importer compliance and support uninterrupted access to the U.S. market.
What Is FDA Registration and Who Really Needs It?
Learn which foreign and domestic companies may need FDA registration before manufacturing, processing, packing, storing, or exporting FDA-regulated products to the U.S. market.
Why Medical Device Establishments Need a U.S. Agent
This designation helps streamline regulatory processes, ensure timely responses to FDA inquiries, and maintain seamless market access in the United States.